Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRENE.L Share News (RENE)

  • There is currently no data for RENE

RENE.L News

ReNeuron Reports Positive Test Results For Blindness Treatment Therapy
26 Apr 2019

ReNeuron Reports Positive Test Results For Blindness Treatment Therapy

LONDON (Alliance News) - ReNeuron Group PLC on Friday reported positive trial results for its human retinal progenitor cell therapy candidate for trea...

DIRECTOR DEALINGS: ReNeuron Chair And Other Board Members Buy Shares
11 Apr 2019

DIRECTOR DEALINGS: ReNeuron Chair And Other Board Members Buy Shares

LONDON (Alliance News) - ReNeuron Group PLC said a number of directors purchased shares on Thursday, including Non-Executive Chair John Berriman who b...

ReNeuron Signs Licence Deal For CTX, hRPC Cell Programmes In China
9 Apr 2019

ReNeuron Signs Licence Deal For CTX, hRPC Cell Programmes In China

LONDON (Alliance News) - ReNeuron Group PLC on Tuesday said it has signed an exclusive licence agreement for the development, manufacture and commerci...

ReNeuron upbeat on progress in hRPC study
4 Apr 2019

ReNeuron upbeat on progress in hRPC study

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group updated the market on progress with its ongoing phase 1 and 2 clinical trial in th...

ReNeuron Shares Rise On Positive Data From Blindness Treatment Trial
4 Apr 2019

ReNeuron Shares Rise On Positive Data From Blindness Treatment Trial

LONDON (Alliance News) - Shares rose in ReNeuron Group PLC on Thursday after it reported positive efficacy in a phase one/two clinical trial of its hR...

ReNeuron Group Starts Dosing Of Second Cohort In hRPC Study
18 Mar 2019

ReNeuron Group Starts Dosing Of Second Cohort In hRPC Study

LONDON (Alliance News) - ReNeuron Group PLC on Monday said it started dosing of the second cohort of patients in a phase II study of its hRPC cell the...

ReNeuron Group begins dosing second cohort in hRPC study
18 Mar 2019

ReNeuron Group begins dosing second cohort in hRPC study

(Sharecast News) - Cell-based therapeutics company ReNeuron Group updated the market on progress with the ongoing phase 1 and 2 clinical trial in the ...

ReNeuron Reports Positive Preliminary Data In US Retinal Trial
20 Feb 2019

ReNeuron Reports Positive Preliminary Data In US Retinal Trial

LONDON (Alliance News) - ReNeuron Group PLC on Wednesday reported "significant improvement in vision" in the trial of its hRPC cell therapy candidate ...